EM-T3Expert Opinion on Drug Safety2024-12-30第 25 卷第 4 期，787-791高影响力 · 前 10%
Influence of rapidly increased numbers of reports on adverse events of the COVID-19 vaccine in the Japanese pharmacovigilance database on disproportionality analysis of antineoplastic drug-associated adverse cardiovascular events
